Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion
More of those on the 3 mg dose lost 5% or more of their total body weight than those on the placebo
Our Collagen Peptides are designed to dissolve instantly in any liquid, hot or cold, making them easy to incorporate whether youre at home or using our convenient travel packs on a mountain top
Seven-day continuous infusion of IGF-1 LR3 in guinea pigs significantly increased the fractional weight of adrenals, gut, kidneys, and spleen compared to controls, indicating tissue growth effects
The difference is not only the clinical format
In the past few decades, cold atmospheric-pressure plasma (CAP) has seen a potential rise in a variety of fields including medicine 2,3
US$ 22.70
US$ 29.57
US$ 24.26
